Singapore Healthcare Bioconvergence Market, 2026-2033
The healthcare bioconvergence market in Singapore is expected to reach a projected revenue of US$ 1,902.4 million by 2033. A compound annual growth rate of 5% is expected of Singapore healthcare bioconvergence market from 2026 to 2033.
- Healthcare IT
- Healthcare Information and Management Systems
- healthcare bioconvergence market report
- Healthcare Information and Management Systems
Revenue, 2025 (US$M)
$1,251.2
Estimate, 2026 (US$M)
$1,349.1
Forecast, 2033 (US$M)
$1,902.4
CAGR, 2026 - 2033
5.0%
Global Market
Related Markets
GVR research-powered AI
Ask Prism AI about the healthcare bioconvergence market report market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Singapore healthcare bioconvergence market highlights
- The Singapore healthcare bioconvergence market generated a revenue of USD 1,251.2 million in 2025 and is expected to reach USD 1,902.4 million by 2033.
- The Singapore market is expected to grow at a CAGR of 5% from 2026 to 2033.
- In terms of segment, drug discovery was the largest revenue generating application in 2025.
- Nanorobotics for Drug Delivery is the most lucrative application segment registering the fastest growth during the forecast period.
Healthcare bioconvergence market data book summary
| Market revenue in 2025 | USD 1,251.2 million |
| Market revenue in 2033 | USD 1,902.4 million |
| Growth rate | 5% (CAGR from 2026 to 2033) |
| Largest segment | Drug discovery |
| Fastest growing segment | Nanorobotics for Drug Delivery |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Nanorobotics for Drug Delivery, Regenerative Medicine, Bioelectronics, Engineered Living Materials, Drug Discovery, Optogenetics, Precision Medicine, Diagnostic and Biological |
| Key market players worldwide | BiomX Inc, Ginkgo Bioworks Holdings Inc, SetPoint Medical, GSK PLC, BICO |
Other key industry trends
- In terms of revenue, Singapore accounted for 0.8% of the global healthcare bioconvergence market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China healthcare bioconvergence market is projected to lead the regional market in terms of revenue in 2033.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 6,324.5 million by 2033.
No credit card required*
Publish Date: Jun 25, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Healthcare Bioconvergence Market Report
Healthcare bioconvergence market report segmentation & scope
Healthcare Bioconvergence Market Report Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GSK PLC | View profile | 70,200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | www.gsk.com |
| SetPoint Medical | View profile | 101-250 | Valencia, California, United States, North America | www.setpointmedical.com |
| BICO | View profile | 501-1000 | Gothenburg, Vastra Gotaland, Sweden, Europe | bico.com |
| BiomX Inc | View profile | 71 | 22 Einstein Street, Floor 4, Ness Ziona, Israel, 7414003 | www.biomx.com |
| Ginkgo Bioworks Holdings Inc | View profile | 1,218 | 27 Drydock Avenue, 8th Floor, Boston, MA, United States, 02210 | www.ginkgobioworks.com |
Singapore healthcare bioconvergence market report
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Healthcare Bioconvergence Market will help companies and investors design strategic landscapes.
Drug Discovery was the largest segment with a revenue share of 21.11% in 2025.
Horizon Databook has segmented the Singapore healthcare bioconvergence market based on nanorobotics for drug delivery, regenerative medicine, bioelectronics, engineered living materials, drug discovery, optogenetics, precision medicine, diagnostic and biological covering the revenue growth of each sub-segment from 2021 to 2033.
- Singapore Healthcare Bioconvergence Market Application Outlook (Revenue, USD Million , 2021-2033)
- Drug Discovery
- Nanorobotics for Drug Delivery
- Regenerative Medicine
- Diagnostic and Biological
- Bioelectronics
- Engineered Living Materials
- Optogenetics
- Precision Medicine
Reasons to subscribe to healthcare bioconvergence market report databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of healthcare bioconvergence market report databook
- Our clientele includes a mix of healthcare bioconvergence market report companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore healthcare bioconvergence market report, including forecasts for subscribers. This country databook contains high-level insights into Singapore healthcare bioconvergence market report from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Singapore Healthcare Bioconvergence Market, 2021-2033 (US$M)
Singapore healthcare bioconvergence market report statistics, by application, 2021-2033 (US$M)
